NEWS&VIEWS 27 Centre Gears up for Food Safety Crisis
Thermo Fisher Scientific has opened a global food testing laboratory devoted to helping contain costly and life-threatening chemical contamination crises. Located in Dreieich, Germany, the Food Safety Response Centre is staffed by world-class chemists who will quickly mobilise to aid governments and businesses in the event of facing unknown chemical contaminant threats. One recent threat, the melamine crisis in China, claimed the lives of at least six children, sickened nearly 300,000 and cost companies worldwide billions before it was contained.
"Identification and containment of food toxicity require a rapid response, otherwise the threat to human health and global commerce is magnified with each passing day," said Marc N. Casper, President
and Chief Executive Officer of Thermo Fisher Scientific. "Chemical contamination in food is a growing and costly threat, including risks from environmental contamination and naturally occurring toxins.”
According to the World Health Organization, chemical contamination in food is a worldwide public health concern and is a leading cause of trade problems internationally.
Common sources of chemical contamination include pesticides, veterinary drugs, banned food dyes, industrial chemicals (such as, acrylamide and benzene), heavy metals (such as, arsenic, cadmium and lead), organic pollutants (such as, dioxins and polycyclic aromatic hydrocarbons) and naturally occurring toxins such as mycotoxins, which can affect peanuts, corn, pistachios and walnuts.
TO FIND OUT MORE CIRCLE NO.
Agilent Completes Acquisition of Varian
Agilent Technologies, Inc announced the completion of its acquisition of scientific-equipment maker Varian, Inc during May. Agilent paid approximately $1.5 billion in cash for Varian in a deal that brings together two Silicon Valley pioneers.
Bill Sullivan, Agilent President and CEO, said, “The Varian acquisition the largest in our company’s history furthers our evolution toward becoming a global leader in bio- analytical measurement. We’re gaining tremendous talent and technology. And for our customers, this will mean a broader span of expertise, applications and products from one trusted company.”
The majority of Varian’s product lines will report into Agilent’s Chemical Analysis Group (CAG), while some key businesses will be housed within Agilent’s Life Sciences Group (LSG).
“This strengthens our leading position in the chemical analysis market,” said Mike McMullen, Agilent Senior Vice President and President of CAG. “The acquisition is a key strategic move for us in the chemical analysis arena, and will serve to fuel our growth trajectory and provide more value to our customers. We will also add a new vacuum technologies business to Agilent, which will continue to operate as a standalone business unit within Agilent.”
A significant new business Agilent gains through the acquisition is Research Products (including NMR, or nuclear magnetic resonance, MRI and X-ray), which will reside in LSG.
“These technology platforms will open new doors for Agilent and its customers,” said Nick Roelofs, Agilent Senior Vice President and President of LSG. “This technology will play a key role in Agilent’s growth through applications such as pharmaceutical and therapeutics. In addition, Agilent can build on its expertise as the worldwide leader in radio frequency (RF) and electromagnetic transmit-and-receive technology by being the first to bring that expertise to the field of magnetic resonance,” he said.
TO FIND OUT MORE CIRCLE NO. 57 55
Phenomenex president and CEO Fasha Mahjoor was amongst other finalists selected for Ernst & Young’s Greater Los Angeles Entrepreneur of the Year 2010 award, which recognises entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities.
responsibility to each other and to the community.
“At Phenomenex, we are not only building a business, but a vibrant culture based on swift initiative, perseverance and This culture enables our
remarkable team in 64 different countries to see and seize opportunities in good times and in adversity using well-defined strategies,” said Mahjoor. The winner of the Entrepreneur of the Year 2010 Award is to be announced later in June.
TO FIND OUT MORE CIRCLE NO. 56
Ariadne and Aureus Pharma Collaborate on Management
Ariadne and Aureus are joining forces with the aim to deliver leading knowledge management solutions for the life sciences industry; Ariadne will also distribute Aureus’ offerings in the US, it was announced.
The two companies are to explore synergies between their respective knowledge management solutions and more particularly the interfaces between the protein pathway space and medicinal chemistry. Such interfaces will help customers to better understand mechanisms of actions between therapeutic proteins, protein pathways and small molecules and provide new insights in the disease biology area it was suggested.
“This engagement highlights the ongoing evolution of Ariadne”, says Ilya Mazo, PhD and CEO. “We believe that this collaboration will make it possible to offer the highest level of interoperability between our companies, along with improved solutions for knowledge management.”
Jason Theodosiou, CEO of Aureus Pharma, commented: “Both companies are innovative and have created solutions that organise high quality data from various sources to better identify, create, distribute, and enable knowledge integration within an organisation.”
TO FIND OUT MORE CIRCLE NO. 58
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204 |
Page 205 |
Page 206 |
Page 207 |
Page 208 |
Page 209 |
Page 210 |
Page 211 |
Page 212 |
Page 213 |
Page 214 |
Page 215 |
Page 216 |
Page 217 |
Page 218 |
Page 219 |
Page 220
